Back to Search
Start Over
A Retrospective Patient Chart Review and Survey in Patients with Cryopyrin-associated Periodic Syndromes Treated with Anakinra
- Source :
- Journal of Health Economics and Outcomes Research
- Publication Year :
- 2013
- Publisher :
- The Journal of Health Economics and Outcomes Research, 2013.
-
Abstract
- **Background:** Cryopyrin-associated periodic syndromes (CAPS) is a group of rare autoinflammatory diseases. Little is known about the burden of disease, patients’ views on treatment, and adverse events (AEs) with current therapy. **Objectives:** The main study objective was to quantify the patients’ burden of disease in terms of flares and resource use and to characterize patient symptomatology and tolerability of treatment with anakinra. A secondary objective included comparing chart review and patient recall of symptoms and AEs. **Methods:** A retrospective medical chart review and concurrent online patient survey was conducted in four European countries. Data 12 months prior to initiation of/during anakinra treatment were entered into web-based case report forms by study groups. **Results:** Forty-two patients received/were receiving anakinra as primary treatment for at least 12 months. Patients experienced a 79.5% reduction in flares after commencing anakinra treatment. During the past 12 months on anakinra, four of five (80%) patients who recalled experiencing flares reported cancelling social activities and staying home as the most common courses of action. Most common AEs were injection site pain upon treatment initiation and weight gain. According to patient recall, 12 of 21 patients (57.1%) discontinued anakinra to enter another clinical trial; of the 12, eight (38%) specifically discontinued anakinra only for that reason, and four patients cited entering a clinical trial as one of many reasons for discontinuing anakinra. **Conclusions:** To our knowledge, this is the most comprehensive survey of patient experience with CAPS. Although improved, CAPS treatment remains suboptimal and a significant burden is placed upon patients, caregivers, and the healthcare system. With new agents available, it will be important to compare outcomes in patients using all therapeutic options.
- Subjects :
- musculoskeletal diseases
Anakinra
Pediatrics
medicine.medical_specialty
business.industry
Health Policy
Public Health, Environmental and Occupational Health
Cryopyrin-associated periodic syndrome
lcsh:Computer applications to medicine. Medical informatics
medicine.disease
medicine
lcsh:R858-859.7
In patient
business
Patient chart
medicine.drug
Subjects
Details
- ISSN :
- 23272236
- Volume :
- 1
- Database :
- OpenAIRE
- Journal :
- Journal of Health Economics and Outcomes Research
- Accession number :
- edsair.doi.dedup.....5be7687a32d36da9a5a0b0138a68a49f
- Full Text :
- https://doi.org/10.36469/9860